View Document Preview and Link Document Date: 2010-09-10 12:20:27 Open Document File Size: 512,41 KB Share Result on Facebook
City Boca Raton / Istanbul / Philadelphia / Maywood / Basel / / Company ATTR / S. Karger AG / CRC Press / / Continent Europe / / Country Switzerland / Congo / Turkey / United States / United Kingdom / / / Facility Loyola University Medical Center / Virchows Arch / / IndustryTerm light/heavy chain / Chemical typing / immunoglobulin light chain / treatment of renal disease / chemical characterization / chemical composition / proper staining protocol / satellite meeting / / MedicalCondition inflammatory response / Cutis laxa / collagenous colitis / familial AA amyloidoses / Renal diseases / light/heavy chain Multiple myeloma / clinical AA amyloidosis / endocrine tumors / hereditary fibrinogen A / systemic AA amyloidosis / hereditary inflammatory disorder / systemic amyloidoses / common hereditary amyloidosis / clinical disease / AL amyloidosis / peripheral neuropathy / systemic disease / Polyneuropathy / systemic AL amyloidosis / suspected cardiac amyloidosis / localized amyloidosis / hereditary apolipoprotein AI amyloidosis / hereditary amyloidosis TTR V30M / gastrointestinal amyloidosis / proteinuria / renal insufficiency / hereditary amyloidoses / renal disease / diarrhea / familial amyloidotic polyneuropathy / hereditary amyloidosis / End-stage renal disease / Lysozyme amyloidosis / constipation / plasma cell dyscrasias / AA amyloidosis / sporadic amyloidoses / hereditary tubulointerstitial nephritis / AL (primary) amyloidosis / dissociation / proteinuria / Renal apolipoprotein A-I amyloidosis / tissues and progressive disease / cardiomyopathy / clinically relevant diseases / disease / monoclonal gammopathies / hypothyroidism / apolipoprotein AII amyloidosis / polyneuropathies / several cerebral amyloidoses / Amyloidosis / chronic hepatitisc A2M / nephrotic syndrome / mimic tumors / Waldenstrom macroglobulinemia / orthostatic hypotension / et al. Three German fibrinogen A␣chain amyloidosis / hereditary types / certain hereditary amyloidoses / heart failure / Renal amyloidosis / cranial neuropathy / systemic amyloidosis / inflammatory disease / hereditary systemic amyloidosis / amyloid cardiomyopathy / chronic hepatitis / Cardiac amyloidosis / renal failure / Amyloidosis-associated kidney disease / Amyloidoses / alpha-chain amyloidosis / disorders / / MedicalTreatment invasive procedure / renal transplantation / chemotherapy / kidney transplantation / counseling / gene therapy / kidney transplant / Dialysis / heart transplant / / Organization Finkl Amyloidosis Foundation / Department of Pathology / 4th Annual Renal Pathology Society / Loyola University Medical Center / Congress / 4th Annual Renal Pathology Society/Kidney and Urology Foundation of America / / Person Maria M. Picken / Arch Pathol Lab Med / Arch Pathol / R. Gallo / Arch Intern / G. Gallo / / Position Ebert MP / Nathrath WB / author / pathologist / / Product dexamethasone / diflunisal / / ProvinceOrState Alabama / Maryland / Illinois / Massachusetts / / Region Mediterranean / / Technology alpha / proteomics / antibodies / transplantation / gene therapy / artificial intelligence / DNA sequencing / chemotherapy / proper staining protocol / Dialysis / / URL http / SocialTag 
Amyloidosis—Where Are We Now and Where Are We Heading? Maria M. Picken, MD, PhD, FASN ● Context.—Amyloidoses are disorders of diverse etiology in which deposits of abnormally folded proteins share distinctive stain